Profile

Founded in late 2016 and based in the UK, Tropic Biosciences is planning to use the revolutionary CRIPSR genome editing technology in developing new commercial varieties of tropical crops (initially coffee and banana). These multi-billion dollar commodities play a critical role in supporting global nutrition and trade income but face intensifying supply-chain and disease challenges. Tropic aim to solve these challenges through non-GMO genetic innovation.